EZH2 Inhibitors: Targeting the Epigenetic Silencer in Cancer and Immunotherapy
EZH2 inhibitors like tazemetostat target the Polycomb Repressive Complex 2, offering new therapeutic options in lymphoma and solid tumors. Discover mechanisms, combinations with immunotherapy, and tool compounds.